使入迷 发表于 2025-3-26 22:51:04

http://reply.papertrans.cn/88/8798/879757/879757_31.png

ANN 发表于 2025-3-27 04:39:41

SGLT2 Inhibitorsomes independent of diabetes status, and even in patients at high risk of renal progression or HF. Future experimental studies are necessary to know whether SGLT2 inhibitors could be used as a goal-directed medical therapy in HF or CKD.

bourgeois 发表于 2025-3-27 06:26:21

http://reply.papertrans.cn/88/8798/879757/879757_33.png

Injunction 发表于 2025-3-27 10:54:26

http://reply.papertrans.cn/88/8798/879757/879757_34.png

eustachian-tube 发表于 2025-3-27 17:30:49

Future Therapies for Diabetess can mature into glucose-responsive beta cells after the transplant in vivo and transplantation methods are available. In addition, gene therapy studies are also being conducted. Other promising therapies include xenotransplantation of porcine pancreatic islets. In this review, I describe their adv

Ancestor 发表于 2025-3-27 20:53:26

Principles of Diabetes Care and Lifestyle Modification

animated 发表于 2025-3-28 01:17:35

http://reply.papertrans.cn/88/8798/879757/879757_37.png

neolith 发表于 2025-3-28 03:45:57

http://reply.papertrans.cn/88/8798/879757/879757_38.png

战胜 发表于 2025-3-28 07:54:17

http://reply.papertrans.cn/88/8798/879757/879757_39.png

Migratory 发表于 2025-3-28 14:26:29

http://reply.papertrans.cn/88/8798/879757/879757_40.png
页: 1 2 3 [4] 5 6
查看完整版本: Titlebook: Stroke Revisited: Diabetes in Stroke; Seung-Hoon Lee,Dong-Wan Kang Book 2021 The Editor(s) (if applicable) and The Author(s), under exclus